Trial Profile
Study of Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate in preventing mother to child HIV transmission
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 28 Nov 2015 New trial record